UnitedHealth Group: Here’s Why Analysts Point to a 100% Upside Scenario

UnitedHealth Group’s stock (UNH) is currently trading significantly below its 52-week high, but analysts see a substantial upside due to anticipated EPS growth in 2026, AI-enabled cost reductions, and strategic investments. Despite a past EPS collapse, forward estimates project a strong recovery, with TIKR’s valuation model targeting over 100% return by 2030, suggesting the market is undervaluing its recovery potential. However, the final 2027 Medicare Advantage rate announcement remains a critical factor for future earnings guidance.